Zobrazeno 1 - 10
of 271
pro vyhledávání: '"Greg L. Plosker"'
Publikováno v:
Drugs & Therapy Perspectives. 33:8-15
The fixed-dose combination of emtricitabine/tenofovir disoproxil fumarate (tenofovir DF) [Truvada®] is approved in the EU for pre-exposure prophylaxis, in conjunction with safer sex practices, to reduce the risk of sexually-acquired HIV-1 infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e90a9b4f4ad677554807ba63707e7f31
https://doi.org/10.1007/s40267-016-0363-9
https://doi.org/10.1007/s40267-016-0363-9
Autor:
Victoria J. Muir, Greg L. Plosker
Publikováno v:
CNS Drugs. 34:447-447
During the creation of the HTML version of the article, incorrect body text (including all tables and figures) and an incorrect Additional Information section were uploaded; the PDF version was correct. The HTML version has now been corrected.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3cf370cb34bc0dc1a35addc4042d71
https://doi.org/10.1007/s40263-020-00712-w
https://doi.org/10.1007/s40263-020-00712-w
Publikováno v:
Drugs & Therapy Perspectives. 32:1-5
A novel formulation of diclofenac sodium suitable for subcutaneous (SC) or intramuscular (IM) injection (Akis®, Dicloin®) has been developed using the complexing agent hydroxypropyl-β-cyclodextrin (HPβCD) as a solubility enhancer. Diclofenac HPβ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ba895f3473d45727fb6fb64764c262b
https://doi.org/10.1007/s40267-015-0258-1
https://doi.org/10.1007/s40267-015-0258-1
Publikováno v:
Drugs & Therapy Perspectives. 31:425-432
Azelastine hydrochloride/fluticasone propionate 137/50 μg nasal spray (henceforth MP-AzeFlu) [Dymista®] provides a combination of two first-line treatments for allergic rhinitis, an intranasal antihistamine and an intranasal corticosteroid, in a si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e51d8a11a8cc5d6a9301a68c0f55b99
https://doi.org/10.1007/s40267-015-0254-5
https://doi.org/10.1007/s40267-015-0254-5
Autor:
Greg L. Plosker, Esther S. Kim
Publikováno v:
Drugs. 75:1679-1686
Afrezza® (insulin human) inhalation powder is a rapid-acting Technosphere® insulin (TI) administered via a breath-powered oral inhaler to patients with diabetes requiring prandial insulin. TI, a dry powdered formulation of recombinant human insulin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0657aef38db34c147b7cf32aae8961a5
https://doi.org/10.1007/s40265-015-0472-0
https://doi.org/10.1007/s40265-015-0472-0
Autor:
Greg L. Plosker
Publikováno v:
Drugs. 75:1535-1546
The 13-valent pneumococcal conjugate vaccine (Prevenar 13(®), Prevnar 13(®)) [PCV13] consists of 13 serotype-specific polysaccharides of Streptococcus pneumoniae (pneumococcus), each covalently conjugated to a non-toxic immunogenic carrier protein.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9769435ac3d5b4cb96cced473c7ad228
https://doi.org/10.1007/s40265-015-0449-z
https://doi.org/10.1007/s40265-015-0449-z
Autor:
Greg L. Plosker
Publikováno v:
Drugs. 75:1255-1268
Acamprosate (Campral(®), Aotal(®), Regtect(®)) is one of a limited number of pharmacological treatment options approved as an adjunct to psychosocial interventions to facilitate the maintenance of abstinence in alcohol-dependent patients. It has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78a939b328b9d18bda213f18db00201
https://doi.org/10.1007/s40265-015-0423-9
https://doi.org/10.1007/s40265-015-0423-9
Autor:
Hannah A. Blair, Greg L. Plosker
Publikováno v:
Clinical Drug Investigation. 35:397-404
A novel formulation of diclofenac sodium suitable for subcutaneous or intramuscular injection (Akis(®), Dicloin(®)) has been developed using the complexing agent hydroxypropyl-β-cyclodextrin (HPβCD) as a solubility enhancer. Diclofenac HPβCD is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011f5e775cbc81741476c11cb3874f72
https://doi.org/10.1007/s40261-015-0294-6
https://doi.org/10.1007/s40261-015-0294-6
Autor:
Greg L. Plosker
Publikováno v:
Drugs. 75:887-897
Memantine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that is a well-established treatment option for moderate to severe dementia of the Alzheimer's type, either alone or in combination with cholinesterase inhibitors. The imme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae8adacf0f32749578ec2ddd16b6fcb
https://doi.org/10.1007/s40265-015-0400-3
https://doi.org/10.1007/s40265-015-0400-3
Autor:
Hannah A. Blair, Greg L. Plosker
Publikováno v:
Targeted Oncology. 10:171-178
Sorafenib (Nexavar®) is the first tyrosine kinase inhibitor to be approved for the treatment of radioactive iodine (RAI)-refractory differentiated thyroid carcinoma (DTC). In the pivotal phase III DECISION trial in patients with RAI-refractory, loca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2265d1593919ed83379e33e0a37d1a
https://doi.org/10.1007/s11523-015-0363-z
https://doi.org/10.1007/s11523-015-0363-z